General Information of Drug Transporter (DT)
DT ID DTD0146 Transporter Info
Gene Name SLC22A23
Transporter Name Solute carrier family 22 member 23
Gene ID
63027
UniProt ID
A1A5C7
Post-Translational Modification of This DT
Overview of SLC22A23 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

24

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A23 Asparagine 24 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC22A23 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

279

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A23 Asparagine 279 has the potential to affect its expression or activity.

O-glycosylation

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

143

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC22A23 Threonine 143 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

284

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 284 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

537

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 537 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC22A23 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

541

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 541 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

548

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 548 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC22A23 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

553

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 553 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

555

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Serine 555 has the potential to affect its expression or activity.

  Threonine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

285

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Threonine 285 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

300

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Threonine 300 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC22A23 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

387

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Threonine 387 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

563

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Threonine 563 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

565

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Threonine 565 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A23 Tyrosine 302 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A23 [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

684

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC22A23 Lysine 684 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S22AN_HUMAN)
2 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
3 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
4 Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
5 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.